Future studies incorporating a larger number of CCA lines and co‐culture systems that include stromal and immune components will be necessary to validate our findings and assess the broader therapeutic relevance of Bcl‐xl inhibition in CCA. Here, BCL2L1 is linked to cholangiocarcinoma.